ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Abstract Number: 1085
    I Work Out: Exercise Appears To Increase FMS Pain
  • Abstract Number: 1632
    Identification Of a Novel Systemic Lupus Erythematosus Risk Locus Between FCHSD2 and P2RY2 In Koreans
  • Abstract Number: 2772
    Identification Of a Sjögren’s Syndrome-Associated Variant That Influences OAS1 Isoform Switching
  • Abstract Number: 1895
    Identification Of Aberrant Pathways In Osteoarthritis Using RNA-Seq
  • Abstract Number: 2063
    Identification Of Autoantibodies To Tyrosyl–Transfer RNA Synthetase Associated With Anti-Synthetase Syndrome
  • Abstract Number: 154
    Identification Of Autoimmune Disease Genes In Regions Under Selection In The Gullah African American Population Of South Carolina
  • Abstract Number: 153
    Identification Of Autoimmune Disease Risk Alleles That Are Under Recent Selection In The Sea Island Gullah African Americans
  • Abstract Number: 2171
    Identification Of Best Cutoff Points and Clinical Signs Specific For Early Recognition Of Macrophage Activation Syndrome In Active Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2085
    Identification Of Clinical Features and Risk Factors Associated With Calcinosis In Adult Patients With Dermatomyositis
  • Abstract Number: 2453
    Identification Of Determinants Of The Functional Outcome In Patients With Early Axial Spondyloarthritis: Results From The German Spondyloarthritis Inception Cohort
  • Abstract Number: 1712
    Identification Of Factors Associated With Agreement Between Rheumatoid Arthritis Electronic Medication Lists and Prescribed Disease Modifying Treatment Plans
  • Abstract Number: 2697
    Identification Of Genetic and Epigenetic Alterations In Spondyloarthritis
  • Abstract Number: 519
    Identification Of IgG4-Related Disease and Analysis Of IgG4 Serum Levels In Different Subgroups Of Patients With Sjögren’s Syndrome
  • Abstract Number: 2799
    Identification Of IL-10 Producing Plasma Cells In Human and Its Deficiency In Systemic Lupus Erythematosus Patients
  • Abstract Number: 176
    Identification Of Major Histocompatibility Complex Class II Alleles Associated With Systemic Sclerosis Through Imputation Strategy
  • Abstract Number: 1702
    Identification of Multiple Genetic Susceptibility Loci in Takayasu’s Arteritis
  • Abstract Number: 1575
    Identification Of Novel Distinct Autoantigen Clusters Reflecting The Heterogeneity Of Systemic Lupus Erythematosus
  • Abstract Number: 1635
    Identification Of Novel Genetic Associations Within Major Histocompatibility Complex (MHC) Class I and Class II In Systemic Lupus Erythematosus (SLE) Patients:  An Examination Of Epitopes Of Early Autoimmunity
  • Abstract Number: 2729
    Identification Of Osteoarthritis Patients With Chronic Inflammation Driven Disease Progression
  • Abstract Number: 1857
    Identification Of SOX5 and SOX6 As Potent Regulators Of RANKL Expression Contributing To Bone Erosion In Rheumatoid Arthritis and Experimental Arthritis Model
  • Abstract Number: 554
    Identification Of Stage Specific Genes Associated With Lupus Nephritis and Response To Remission induction  In NZB/W Mice
  • Abstract Number: 111
    Identifying Groups At Increased Risk Of Developing Rheumatoid Arthritis Using Family History and Genetic Risk Scores
  • Abstract Number: 129
    Identifying Predictors Of A Fibromyalgia Diagnosis: A Retrospective Electronic Medical Record Analysis
  • Abstract Number: 1744
    Identifying Trajectories of Lung Function Change Over Time in Scleroderma
  • Abstract Number: 36
    IFN-α Induces Altered Transitional B Cell Signaling and Function In Systemic Lupus Erythematosus
  • Abstract Number: 2636
    IgA Vasculitis – The Second Most Common Systemic Vasculitis In Adults In Slovenia
  • Abstract Number: 2635
    IgA Vasculitis In Adults – a Rare and Benign Disease?
  • Abstract Number: 31
    IgD- CD27- B Cells From Systemic Lupus Erythematous Patients Have Increased Expression Of Genes Involved In RNA Sensing and Toll-Like Receptor 3 Signaling Pathways
  • Abstract Number: 2654
    IgG Antibodies Directed Against Domain I Of ß2-Glycoprotein I Are Significant Predictors Of Thromboembolic Events In Patients With Antiphospholipid Antibodies. A Prospective Cohort Study
  • Abstract Number: 1099
    IgG Autoantibodies Against p29ING4 In Early-Stage Type I Complex Regional Pain Syndrome (CRPS) and In Other Inflammatory Diseases Involving The Joints
  • Abstract Number: 2023
    IgG4-Related Midline Destructive Lesion: Expanding The Spectrum Of Organ Involvement In IgG4-Related Disease
  • Abstract Number: 784
    IgG4+ Plasmablasts Are A Novel Biomarker In IgG4-Related Disease
  • Abstract Number: 809
    IgM Rheumatoid Factor As a Potentiator Of Anti-Citrullinated Protein Antibody Mediated Inflammation In Rheumatoid Arthritis
  • Abstract Number: 2822
    IKKε Deficiency Prolongs Neutrophil Survival Paradoxically Prolonging Inflammation In The Absence Of a Type I Interferon Response
  • Abstract Number: 1637
    IKZF1 Modulates PP2Ac Expression Through An Intronic Binding Site
  • Abstract Number: 2503
    IL-17+ CD8+ T Cells Are Enriched In The Joints Of Patients With Psoriatic Arthritis and Correlate With Markers Of Disease Activity and Joint Damage Progression
  • Abstract Number: 2713
    IL-21 Inhibited Follicular Regulatory T Cells To Promote Autoreactive Germinal Center Development In Autoimmune BXD2 Mice
  • Abstract Number: 634
    IL-21/IL-21R Interaction On Lymphocyte Subsets From Lupus Patients
  • Abstract Number: 1289
    IL-6 Is Required For Th1- and Th17- Mediated Arthritis
  • Abstract Number: 1855
    IL-6 Promotes Systemic Bone Loss Via Upregulation Of S1PR2 In Osteoclast Precursors In a Mouse Collagen-Induced Arthritis Model
  • Abstract Number: 1823
    IL-6 Suppresses Osteoblast Differentiation Through The SHP2/MEK2 and SHP2/Akt2 Pathways In Vitro
  • Abstract Number: 915
    IL-6R Inhibition Reduces Activation Of Different Peripheral Memory B Cell Subsets In RA
  • Abstract Number: 1763
    IL4-10 Synerkine: A Novel Immunoregulatory Drug To Prevent Immunopathology In Rheumatic Diseases
  • Abstract Number: 667
    IL6 and CCL2 Co-Regulate Fibroblast Dependent Trans-Endothelial Migration Of Mononuclear Cells and Fibrotic Response In Scleroderma
  • Abstract Number: 1941
    Imaging Atherosclerotic Plaque Inflammation In RA: Methodology and Initial Findings In a Single Centre Cohort
  • Abstract Number: 1826
    Immune Complex Formation By Adalimumab Contributes Significantly To Its Inhibitory Effect On TNF-Enhanced Human Osteoclast Development Even In The Absence Of Fc Receptor Binding
  • Abstract Number: 572
    Immunization With Hepatitis B Vaccine Accelerates SLE-Like Disease In An Animal Model
  • Abstract Number: 2739
    Immunochip Analysis Identifies New Susceptibility Loci For Systemic Sclerosis: Implications For Pathogenesis
  • Abstract Number: 1444
    Immunogenicity Induced By Tumor Necrosis Factor Antagonists In Chronic Inflammatory Arthropathies: Retrospective Study In Clinical Practice Conditions
  • Abstract Number: 2628
    Immunogenicity Of Infliximab Modulates Efficacy and Safety In Behcet’s Disease Patients With Uveitis
  • Abstract Number: 2484
    Immunogenicity Of TNFα Blockers In Patients With Psoriatic Arthritis
  • Abstract Number: 1509
    Immunogenicity, Adalimumab Levels and Clinical Response In Ankylosing Spondylitis Patients During 24 Weeks Of Follow-Up
  • Abstract Number: 2727
    Immunologic and Inflammatory Markers Of Impending Disease Flare In Systemic Lupus Erythematosus Patients Not Taking Immunosuppressive Medications In The Biomarkers Of Lupus Disease (BOLD) Study
  • Abstract Number: 1864
    Immunologic Markers and Molecular Mechanisms Associated With Increased Systemic Lupus Erythematosus Activity In Patients Not Taking Immunosuppressive Medications
  • Abstract Number: 1276
    Immunologic Monitoring and Infectious Complications In Pediatric Rheumatology Patients Treated With Rituximab
  • Abstract Number: 963
    Impact Of a Nurse-Led Program On Comorbidity Management In Rheumatoid Arthritis (RA): Results Of a Prospective, Multicenter, Randomized, Controlled Trial
  • Abstract Number: 2684
    Impact Of Anti-Rheumatic Treatment On Immunogenicity Of Pandemic H1N1 Influenza Vaccine In Patients With Arthritis
  • Abstract Number: 1174
    Impact Of Bariatric Surgery On Serum Urate Targets in People With Morbid Obesity and Diabetes: A Prospective Longitudinal Study
  • Abstract Number: 1808
    Impact Of Baseline Disease Severity and Treatments On Outcomes In Clinical Trials Of SLE:  Results From The Soccit Program
  • Abstract Number: 1026
    Impact Of Basing Rheumatoid Arthritis Disease Activity Measurement and Treatment Recommendations On Patient Instead Of Physician Joint Assessments
  • Abstract Number: 1038
    Impact Of Biological Treatment On Overall Mortality and On Incidence Of Second Cancers In Arthritis Patients – A Follow-Up Study From The Danish Danbio Registry
  • Abstract Number: 757
    Impact Of Cardiac Magnetic Resonance Imaging On Eosinophilic Granulomatosis With Polyangiitis Outcomes: A Long-Term Retrospective Study On 42 Patients
  • Abstract Number: 2392
    Impact Of CT-P13 and Originator Infliximab Treatment On Quality Of Life Derived From The Health Assessment Questionnaire (HAQ) and Short-Form 36 (SF-36) From a Randomized, Double-Blind Trial In Patients With Active RA
  • Abstract Number: 2880
    Impact Of Different End Points On The Patient Cohort Size Needed To Demonstrate The Efficacy Of a Therapeutic Intervention In Pss. A Post Hoc Analysis Of The Tears Study (Tolerance and efficacy of Rituximab in primary Sjogren Syndrome study)
  • Abstract Number: 1267
    Impact Of Disease Duration On Vascular Surrogates Of Early Atherosclerosis In Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1984
    Impact Of Educational Attainment On Health-Related Quality Of Life and Healthcare Utilization Among Veterans With Gout
  • Abstract Number: 2359
    Impact Of Etanercept-Methotrexate Treatment Withdrawal On Patient-Reported Outcomes In Patients With Early Rheumatoid Arthritis (PRIZE Trial)
  • Abstract Number: 2311
    Impact Of Healing Architecture In a Rheumatology Outpatient Clinic
  • Abstract Number: 453
    Impact Of Inadequate Adherence On Clinical Outcomes: Results From The Biologics In Rheumatoid Arthritis Genetics and Genomics Study Syndicate Cohort
  • Abstract Number: 314
    Impact Of Low Infliximab Dose Regimen On Treatment Response and Drug Survival In 462 Patients With Psoriatic Arthritis. Results From The Nationwide Registries Danbio and Icebio
  • Abstract Number: 675
    Impact Of Male Sex On Survival In Systemic Sclerosis
  • Abstract Number: 2686
    Impact of Methotrexate Dose Reduction Upon Initiation of Adalimumab On Clinical and Ultrasonographic Parameters in Patients With Moderate to Severe Rheumatoid Arthritis
  • Abstract Number: 2538
    Impact Of Omega-3 Fatty Acids On Quality Of Life In Systemic Lupus Erythematosus
  • Abstract Number: 341
    Impact Of Persistent Minimal Disease Activity On Long-Term Outcomes In Psoriatic Arthritis: Results From 5 Years Of The Long Term Extension Of a Randomized, Placebo-Controlled, Study
  • Abstract Number: 2317
    Impact of PVA Coated Nanoparticles On Cellular Viability and Functionality of Immune Cells Obtained From Healthy Donors and Patients With Rheumatoid Arthritis Or Osteoarthritis
  • Abstract Number: 2477
    Impact Of Stressful Life Events On Disease Activity In Spondyloarthritis: Results Of The Coenv-2 Prospective Cohort Study
  • Abstract Number: 857
    Impact of Urate Lowering Therapy On Renal Disease Progression in Patients With Hyperuricemia
  • Abstract Number: 2145
    Impact On Cartilage Volume Changes Over Time Of Conventional Treatment and Of Glucosamine and Chondroitin Sulfate In Knee Osteoarthritis Patients: Data From The Osteoarthritis Initiative Cohort
  • Abstract Number: 2696
    Impaired Bacterial Clearance and An Exuberant Inflammatory Response Promote Chlamydia-Induced Reactive Arthritis In SKG Mice
  • Abstract Number: 2096
    Impaired Shoulder-Arm Mobility and Muscle Function In Patients With Systemic Sclerosis
  • Abstract Number: 2425
    Impaired TNFá Production By Dendritic Cells From Rheumatoid Arthritis Patients Upon Contact With Porphyromonas Gingivalis
  • Abstract Number: 1690
    Impaired Vitamin D Receptor Signaling Upregulates Transforming Growth Factor Beta (TGFβ) Signaling In Systemic Sclerosis
  • Abstract Number: 189
    Implementation Of a Methotrexate Self-Injection Education Video – Reducing Teaching Time While Maintaining Patient Confidence and Knowledge
  • Abstract Number: 2666
    Implementing a Personalized Health Plan To Improve Therapeutic Outcomes In Veterans With Gout
  • Abstract Number: 1973
    Importance Of Hand Positioning In 3D Joint Space Morphology Assessment
  • Abstract Number: 2137
    Important Predictors Of Patient-Reported Outcomes After TKR and THR Are Not Included In Risk Models Based On Administrative Data
  • Abstract Number: 2529
    Improved Outcomes In High Risk Lupus Pregnancies: Usefulness Of a Protocol Based Multidisciplinary Approach In Kerala, India
  • Abstract Number: 2154
    Improvement In Clinical Symptoms After 48 Weeks Of Wearing Flexible Footwear In Osteoarthritis Of Knee: A Randomized Placebo-Controlled Study
  • Abstract Number: L5
    Improvement in High Density Lipoprotein Function in Early Rheumatoid Arthritis Patients Treated with Methotrexate Monotherapy or Combination Therapy in the Treatment of Early Rheumatoid Arthritis Trial
  • Abstract Number: 2766
    Improvement In Insulin Resistance Greater With The Use Of Infliximab Following Intensive Treatment Of Early Rheumatoid Arthritis
  • Abstract Number: 2459
    Improvement In Physical Function, Health-Related Quality Of Life, and Work Productivity With Adalimumab Treatment In Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: L7
    Improvement in Psoriasis Symptoms and Physical Functioning with Secukinumab Compared with Placebo and Etanercept in Subjects with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Results of a Subanalysis from the Phase 3 Fixture Study
  • Abstract Number: 2329
    Improvements In Physical Function Correlate With Improvements In Health Related Quality Of Life: Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib: Results From 3 Randomized Phase 3 Trials
  • Abstract Number: 987
    Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention
  • Abstract Number: 845
    Improving Pneumococcal Vaccination Rate In The Pediatric Rheumatology Clinic
  • Abstract Number: 1789
    In Early Rheumatoid Arthritis, The 12 Individual Biomarkers That Comprise The Multiple Biomarker Disease Activity Score Relate Differentially To Clinical Response and Radiographic Progression: Results From a Randomized Trial
  • Abstract Number: 2379
    In Rheumatoid Arthritis Patients With Stable Low Disease Activity On Methotrexate Plus Etanercept, Continuation Of Etanercept Is Superior Both Clinically and Radiographically To Discontinuation: Results From a Randomized, 3-Armed, Double-Blind Clinical Trial
  • Abstract Number: 2394
    In Rheumatoid Arthritis, Smoking Is Not Primarily Associated With Anti-Citrullinated Protein Antibodies, But With The Presence Of Multiple Autoantibodies
  • Abstract Number: 1619
    In Vitro Assessments Of Mesenchymal Stem Cells From Lupus Patients To Predict Suppressive Function In Vivo
  • Abstract Number: 2554
    In Vitro Fertilization In Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Series Of 82 Cycles
  • Abstract Number: 2722
    In Vivo Administration Of MiR-146a Protects C57BL/6 Mice From Pristane-Induced Pulmonary Hemorrhage Via Suppressing Type I Interferon Response
  • Abstract Number: 1828
    In Vivo Cartilage-Specific Deletion Of Ephrin-B2 In Mice Results In Developmental Locomotory Defects Associated With Hip Bone Abnormality
  • Abstract Number: 2737
    In Vivo MiR-146a Administration Ameliorates Murine Lupus Nephritis
  • Abstract Number: 570
    In Vivo Therapeutic Success Of Microrna-155 (miR-155) Antagomir In a Mouse Model Of Lupus Pulmonary Hemorrhage
  • Abstract Number: 2537
    Inactive Systemic Lupus Erythematosus: Cytokines and Soluble Tumor Necrosis Factor Receptors Response To Moderate/Intense Exercise
  • Abstract Number: 1281
    Inadequate Glucocorticoid Secretion in Experimental Arthritis in Rats Is Closely Linked to Impaired Mitochondria and Reduced Lipid Breakdown in the Adrenal Cortex
  • Abstract Number: 1067
    Incidence and Prevalence Of Systemic Lupus Erythematosus: A 2010 Nation-Wide Population-Based Study Using French National Administrative Databases
  • Abstract Number: 2760
    Incidence and Severity Of Myocardial Infarction In Subjects Receiving Anti Tumour Necrosis Factor Drugs For Rheumatoid Arthritis: Results From Linking the British Society For Rheumatology Biologics Register For Rheumatoid Arthritis and Myocardial Ischaemia National Audit Project
  • Abstract Number: 97
    Incidence and Trend Of Osteoarthritis In An Administrative Database From British Columbia, Canada
  • Abstract Number: 2362
    Incidence Of Adverse Events In Patients With Rheumatoid Arthritis and Spondyloarthritis Exposed To Anti-TNF Therapy. Data From The Brazilian Registry For Monitoring Of Biologic Therapies In Rheumatic Diseases (BiobadaBrasil)
  • Abstract Number: 1218
    Incidence Of and Risk Factors For Clinical Fractures In Patients With Systemic Lupus Erythematosus and Matched Controls: A Population-Based Study In The United Kingdom
  • Abstract Number: 1080
    Incidence Of Coronary Heart Disease Associated With Arthritis: A Canadian Population-Based Cohort Study
  • Abstract Number: 2360
    Incidence Of Diabetes and Effect Of Etanercept and Adalimumab On HbA1c Over 1 Year: Data From a Randomised Trial In Patients With Rheumatoid Arthritis
  • Abstract Number: 1365
    Incidence Of Hepatitis B Virus Reactivation In Patients With Rheumatoid Arthritis During Treatment With Biologics
  • Abstract Number: 305
    Incidence of Herpes Zoster in Patients with Psoriatic Arthritis
  • Abstract Number: 1037
    Incidence Of Malignancy In Patients With Rheumatoid Arthritis From a Japanese Large Observational Cohort (NinJa)
  • Abstract Number: 104
    Incidence Of Osteoporotic Hip Fractures In Estonia Between 2005 and 2012
  • Abstract Number: 2679
    Incidence Rates Of Serious Infections and Infection Subtypes Among Pediatric Systemic Lupus Erythematosus Patients Enrolled In Medicaid, According To Medication Use
  • Abstract Number: 2682
    Incidence Trends and Predictors Of Orthopedic Surgery In Patients With Rheumatoid Arthritis – Results From a Well Defined Population
  • Abstract Number: 970
    Incorporating The Health Literacy Universal Precautions Toolkit Quick Start In Academic Rheumatology Practices: Carolina Fellows Collaborative
  • Abstract Number: 609
    Increased Arterial Stiffness In Systemic Lupus Erythematosus (SLE) Patients At Low Risk For Cardiovascular Disease: A Cross-Sectional Controlled Study
  • Abstract Number: 2833
    Increased Cardiac Septal Defects In Children Born To Women With Systemic Lupus Erythematosus: Results From The O S L E R Study
  • Abstract Number: 1840
    Increased Expression of BAFF Receptor On Monocytes Is a Contributory Factor of Hypergammaglobulinemia in Patients With Primary Sjögren’s Syndrome
  • Abstract Number: 1494
    Increased Expression Of Interleukin 33 In Sera and Salivary Gland From Patients With Sjögren Syndrome
  • Abstract Number: 612
    Increased Expression Of Membrane Endothelial Protein C Receptor Associates With Poor Response In Lupus Nephritis Independent Of Chronicity Index 
  • Abstract Number: 1143
    Increased Frequency Of Pratroling Monocytes In Experimental Arthritis and Rheumatoid Arthritis Patients In Response To IL6-R Blockade
  • Abstract Number: 712
    Increased IL-23 Receptor Expression Is Observed On KIR3DL2+ CD4+ T Cells In Ankylosing Spondylitis and Correlates With IL-23R Polymorphisms
  • Abstract Number: 383
    Increased Incidence Of Low-Energy Fractures In Rheumatoid Arthritis Patients
  • Abstract Number: 2676
    Increased Pulse Wave Velocity In Juvenile Idiopathic Arthritis Patients Compared To Controls From The General Population
  • Abstract Number: 896
    Increased Rho Kinase (ROCK) Activity In Temporal Artery Biopsies From Patients With Giant Cell Arteritis (GCA)
  • Abstract Number: 2831
    Increased Risk Of Autism Spectrum Disorders In Children Born To Women With SLE: Preliminary Data From The O S L E R Cohort
  • Abstract Number: 2712
    Increased Soluble PD-1: A Link Between Generation Of Immunological Memory and Risk Of Disease Flare In Early RA
  • Abstract Number: 2084
    Increasing Incidence Of Immune Mediated Necrotizing Myopathy In A Single Center
  • Abstract Number: 969
    Increasing Rheumatology Exposure To Internal Medicine Residents: 3 Year Analysis Of A Web-Based Image Of The Month
  • Abstract Number: 1076
    Individuals With Knee Or Hip OA and Low SES Are Likely To Be Physically Active
  • Abstract Number: 810
    Inducible Bronchus Associated Lymphoid Tissue In The Lung Is Associated With Seropositivity For Rheumatoid Arthritis-Related Autoantibodies In Subjects With and Without Clinically Diagnosed Rheumatoid Arthritis
  • Abstract Number: 1420
    Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab. Results Of a 2-Year Trial (OPERA)
  • Abstract Number: 491
    Infection Risk Among Patients Receiving Concurrent Denosumab and Biologic Or Non-Biologic DMARD Therapy: An Analysis Of The Consortium Of Rheumatology Researchers Of North America (CORRONA) Registry
  • Abstract Number: 1507
    Infection Risk in Ankylosing Spondylitis: Results From a Longitudinal Observational Cohort
  • Abstract Number: 2166
    Infection Risk With Tumor Necrosis Factor Inhibitor Use In Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 1675
    Infections Requiring Or Acquired During Hospitalizations In Patients With Giant Cell Arteritis – a Population Based Retrospective Cohort Study
  • Abstract Number: 2016
    Inflamamatory Myositis-Increased Incidence In Fire Department Of New York Firefighters After World Trade Center Exposure
  • Abstract Number: 2841
    Inflammation and Structural Progression In The Sacroiliac Joints Of Patients With Axial Spa Treated With Adalimumab Or Placebo As Assessed By The Berlin and The Spondyloarthritis Research Consortium Of Canada MRI Methods
  • Abstract Number: 1539
    Inflammation In The Posterior Elements Of The Spine Is Infrequent In Patients With Recent Onset Axial Spondyloarthritis, Especially If No Inflammation In The Vertebral Bodies Is Observed
  • Abstract Number: 2523
    Inflammatory Arthritis Activity During Pregnancy In Systemic Lupus Erythematosus
  • Abstract Number: 268
    Inflammatory Bowel Disease In Juvenile Idiopathic Arthritis Patients Upon Biologics
  • Abstract Number: 358
    Inflammatory Burden Predicts Carotid Plaque Progression and Subsequent Cardiovascular Events In Rheumatoid Arthritis: The 2-Year Prospective Cohort Study
  • Abstract Number: 371
    Inflammatory Cell Infiltrates In The Heart Of Patients With Coronary Artery Disease With and Without Inflammatory Rheumatic Disease: A Biopsy Study
  • Abstract Number: 764
    Inflammatory Disease Due To Dysregulated Nuclear Factor-κB Activation and Impaired Type I Interferon Response Resulting From a De Novo Human NEMO Hypomorphic Mutation
  • Abstract Number: 2077
    Inflammatory Lung Disease a Potential Risk Factor For Onset Of Inflammatory Myopathies
  • Abstract Number: 2626
    Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet’s Syndrome
  • Abstract Number: 2060
    Influence Of Anti-Ro/SSA Autoantibodies On Cinical Characteristic Of a Cohort Of Myositis Patients
  • Abstract Number: 2305
    Influence Of Disease Activity On The Physical Activity Of Rheumatoid Arthritis Patients
  • Abstract Number: 2856
    Influence Of Mechanical Symptoms On Treatment Outcomes For Meniscal Tear In The Setting Of Osteoarthritis
  • Abstract Number: 811
    Influence Of Smoking On Citrullinated Proteins and Porphyromonas Gingivalis In The Lung: A Priming Site For Autoimmunity In RA
  • Abstract Number: 1515
    Influence Of Taking Structural Lesions Into Account In Addition To Inflammatory Lesions On MRI Of The Sacroiliac Joints On The Classification Of Patients With Possible Axial Spondyloarthritis
  • Abstract Number: 531
    Influenza Infection Of MHC-I Transgenic Mice Reveals That Erap Is Necessary and Sufficient For Generation Of The B27-Specific Immunodominant Epitope
  • Abstract Number: 543
    Inhibiting TWEAK (TNF-like weak inducer of apoptosis) Signaling Improves Blood Brain Barrier Integrity and Protects From Neuronal Damage In Murine Neuropsychiatric Lupus
  • Abstract Number: 2732
    Inhibition Of Autophagy Prevents Ovariectomy Induced Bone Loss
  • Abstract Number: 42
    Inhibition Of B Cell Differentiation To The Plasmablast and Plasma Cell Lineage By CC-220, a Potent Modulator Of The Cereblon E3 Ubiquitin Ligase Complex
  • Abstract Number: 557
    Inhibition of Calcium/Calmodulin-Dependent Protein Kinase 4 Ameliorates Th17 Related Autoimmune Disorder
  • Abstract Number: 822
    Inhibition Of Casein Kinase II Reduces TGFβ Induced Fibroblast Activation and Ameliorates Experimental Fibrosis
  • Abstract Number: 1792
    Inhibition Of Chemokine Receptors CCR1 and CCR6 As Promising Therapies For Autoimmune Diseases Such As Rheumatoid Arthritis and Psoriasis
  • Abstract Number: 2858
    Inhibition Of Chronic Pain By IL4-10 Synerkine Is Superior To IL-4 Or IL-10 Monotherapy: A Novel Strategy To Restrain Pain In Rheumatic Diseases
  • Abstract Number: 2705
    Inhibition Of Microrna-155 Ameliorated Experimental Fibrosis By Suppressing Wnt and Akt Pathways
  • Abstract Number: 2562
    Inhibition Of SOX9 Phosphorylation Abrogates The Increased Expression Of Profibrotic Genes In Systemic Sclerosis Dermal Fibroblasts
  • Abstract Number: 1426
    Inhibition Of Spermidine/Spermine N1-Acetyltransferase Activity – a New Therapeutical Concept In Rheumatoid Arthritis
  • Abstract Number: 762
    Inhibition Of TGF-Beta Signaling In Articular Chondrocytes Leads To OA-Like Pathological Defects and Pain-Related Behavior Change In Mice
  • Abstract Number: 768
    Inhibition Of X-Box Binding Protein 1 (XBP1) Is Chondroprotective By Promoting Autophagy and Inhibiting Catabolic Responses
  • Abstract Number: 552
    Inhibitor Of Differentiation 3, A Transcription Factor Regulates Susceptibility To Kidney Disease
  • Abstract Number: 937
    Inhibitor Of DNA Binding 1 Mediates Angiogenesis In Rheumatoid Arthritis By Recruitment Of Endothelial Progenitor Cells
  • Abstract Number: 1457
    Inhibitory Effect Of Abatacept On Joint Damage In Rheumatoid Arthritis Patients With Or Without Concomitant Methotrexate: A Retrospective Multicenter Analysis Of 12 Months Of Abatacept Treatment In Routine Clinical Practice
  • Abstract Number: 1265
    Initial Benchmarking Of The Quality Of Medical Care Of Children and Adolescents With Lupus
  • Abstract Number: 1348
    Initial Combination Therapy In Early Rheumatoid Arthritis: Which Patients Benefit?
  • Abstract Number: 2026
    Initial Dose Of Prednisolone For Japanese Patients With Polymyalgia Rheumatica
  • Abstract Number: 1693
    Initial Triple DMARD Therapy Is More Efficient Than Methotrexate Monotherapy In Recent Onset Rheumatoid Arthritis; 1-Year Data Of a Randomized Clinical Trial (tREACH)
  • Abstract Number: 1022
    Initiation Of Biologic Therapy: The Patient Perspective
  • Abstract Number: 1168
    Innate Immune Cell Production Of Interleukin-12 Drives CpG-Induced Macrophage Activation Syndrome
  • Abstract Number: 90
    Insufficient Evidence For An Increase In Prevalence and Incidence Of Gout: A Systematic Review and Meta-Regression Analysis
  • Abstract Number: 391
    Insulin Resistance As A Risk Factor For Subclinical Atherosclerosis In Rheumatoid Arthritis
  • Abstract Number: 1117
    Integrated 18f-Fluoride Positron Emission Tomography and Magnetic Resonance Imaging Of The Spine – a Pilot Study and Comparison Of Signals In Patients With Axial Spondyloarthritis
  • Abstract Number: 2912
    Integrating Patient Electronic Health Records With An Electronic Data Capture System In a Biologics Registry For Inflammatory Arthritides
  • Abstract Number: 2735
    Integrative Analysis Of Multiple Omics Technologies Reveals a Novel Therapeutic Target For Rheumatoid Arthritis (RA)
  • Abstract Number: 978
    Inter-Professional Training Programs For Primary Care Providers Can Successfully Educate Practitioners With Dramatically Different Educational and Training Background Through a Common Mini-Residency Training Program
  • Abstract Number: 2187
    Inter-Rater Reliability Of Jumping Mechanography In Healthy Children and Adults
  • Abstract Number: 2657
    Interactions Between Cigarette Smoking, Body Mass Index and Inflammatory Cytokine Levels In Determining The Risk Of Developing Rheumatoid Arthritis
  • Abstract Number: 69
    Interconnected Cellular Projections and Gap Junctions Mediate Metabolic Coupling Between Chondrocytes Located In Different Layers Of The Tissue: Cell-To-Cell Communication In Normal and Osteoarthritic Cartilage
  • Abstract Number: 713
    Interferon Regulatory Factor 2 Haploinsufficiency Deteriorates Imiquimod-Induced Psoriasis-Like Skin Inflammation
  • Abstract Number: 1899
    Interferon Regulatory Factor 5 Gene Variant rs2004640 Is Associated With Carotid Intimal Medial Thickness In Rheumatoid Arthritis Patients
  • Abstract Number: 1616
    Interferon Regulatory Factors 3 and 5 As Key Elements Of The Interferon Signature On Plasmacytoid Dendritic Cells From Systemic Lupus Erythematosus Patients
  • Abstract Number: 1656
    Interferon Type I and T Helper 17: A Dangerous Liaison In Primary Sjögren’s Syndrome?
  • Abstract Number: 2082
    Interferon-Regulated Chemokine and Innate Cytokine Scores Identify Refractory Myositis Patients That Respond Better To Rtuximab Therapy
  • Abstract Number: 959
    Interleukin 10 Negatively Correlates With Glycoprotein VI-Related Platelet Activation In Rheumatoid Arthritis (RA): A Novel Potential Target Of Cardiovascular Morbidity In RA
  • Abstract Number: 1887
    Interleukin-1 Receptor Antagonist (IL-1Ra) Plasma Levels Predict Radiographic Progression Of Symptomatic Knee Osteoarthritis Over 24 Months
  • Abstract Number: 934
    Interleukin-12B Is Up-Regulated By Decoy Receptor 3 In Specifically Rheumatoid Synovial Fibroblasts
  • Abstract Number: 2493
    Interleukin-17 Serum Levels Are Associated With Markers Of Systemic Inflammation In Patients With Active Ankylosing Spondylitis
  • Abstract Number: 946
    Interleukin-34 Regulates Angiogenesis and Cell Proliferation In Inflammatory Arthritis, This Effect Is Potentiated By Hypoxia
  • Abstract Number: 710
    Interleukin-6 Driven STAT3 Phosphorylation In Circulating Lymphocytes Is Specific For CD4+ T Cells In Early Rheumatoid Arthritis
  • Abstract Number: 894
    Intermittent Fever, Immune Dysregulation, and Systemic Vasculopathy Due To Loss-Of-Function Mutations In Adenosine Deaminase2
  • Abstract Number: 2141
    Interphalangeal Intra-Articular Injection With Triamcinolone Hexacetonide: Assessment Of effectiveness  In Hand Osteoarthritis
  • Abstract Number: 1909
    Interpretation Of Patient Reported Outcomes Measurement Information System (PROMIS) By Rheumatologists
  • Abstract Number: 2191
    Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis: A PILOT Study
  • Abstract Number: 2893
    Intestinal Microbiota Plays a Critical Role In The Production Of Antinuclear Antibodies In Lymphopenia-Induced Autoimmunity
  • Abstract Number: 1386
    Intracellular Concentration Of Methotrexate Is Influenced By Polymorphisms Of Gamma-Glutamyl Hydrolase Gene In Japanese Patients With Rheumatoid Arthritis
  • Abstract Number: 2768
    Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety In Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: 2-Year Results Of a Phase 3 Trial Of Intravenous Golimumab
  • Abstract Number: 708
    Intravenous Immunoglobulin May Be An Effective Therapy In Scleroderma Patients With Refractory Active Diffuse Cutaneous Disease
  • Abstract Number: 537
    Investigating a Novel Locus For Psoriatic Arthritis
  • Abstract Number: 1858
    Investigating The Role Of IL-22 In The Pathogenesis Of Familial Mediterranean FEVER
  • Abstract Number: 2424
    Investigation Of The Role Of Histone Deacetylases In Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 63
    Investigations On The Role Of Delta/Notch Like EGF-Related Receptor In The Pathogenesis Of Osteoarthritis
  • Abstract Number: 2210
    Involvement In Leisure Activities Among Children and Youth With Juvenile Idiopathic Arthritis
  • Abstract Number: 2568
    Involvement Of Collagen-Binding Heat Shock Protein 47 In The Scleroderma-Associated Fibrosis
  • Abstract Number: 2226
    Involvement Of Suppressor Of Cytokine Signaling In Anti-Arthritic Effect Induced By Anti-IL-6 Receptor Antibody
  • Abstract Number: 666
    Involvement Of TCR Vdelta1+ NKT Cells In Systemic Sclerosis: Association With Interstitial Pneumonia
  • Abstract Number: 2393
    Involvement Of Transitional T Follicular Like Helper Cells Bearing Triple Phenotypes Of Tfh/Th1/Th17 In The Pathogenesis Of Rheumatoid Arthritis
  • Abstract Number: 2371
    Is a Single Variable, The Swollen Joint Count, Valid As An Outcome Measure Separate From Being In An Index Measure? An Analysis From The Prospective, Biologic Treatment Registry Across Canada
  • Abstract Number: 577
    Is An Excess Risk Of Attention Deficit Hyperactivity Disorder In Children Born To Women With SLE Mediated By In Utero Drug Exposures? Preliminary Data From The O S L E R Cohort
  • Abstract Number: 2629
    Is Complete Remission a Realistic Target With Current Therapeutic Options in Behçet’s Disease ?
  • Abstract Number: 2380
    Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy?
  • Abstract Number: 1803
    Is Site Of Back Pain Related To Location Of Inflammatory and Structural Lesions On MRI In Patients With Chronic Back Pain?
  • Abstract Number: 1443
    Is The Risk Of Tumor Necrosis Factor Inhibitor-Induced Lupus The Same With Monoclonal Antibodies and Soluble Receptor? A Case/Non-Case Study In a Nationwide Pharmacovigilance Database
  • Abstract Number: 829
    Is The Severity Of Knee Osteoarthritis On MRI Associated With Outcome Of Exercise Therapy?
  • Abstract Number: 2440
    Is There a Role For Etoricoxib In Patients With Axial Ankylosing spondylitis  Refractory To Traditional NSAID?
  • Abstract Number: 262
    Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee
  • Abstract Number: 508
    Is Ultrasonography Of Salivary Gland a Validate Tool In Sjögren Syndrome? Study 1: Interobserver Reliability Between International Group Of Experts
  • Abstract Number: 1096
    Is Vitamin D Deficiency a Risk Factor For The Development Of Statin Induced Myalgia, In Patients Treated With Statin?
  • Abstract Number: 2616
    Ischemia-Modified Albumin : A Novel Marker of Vascular Involvement in Behcet’s Disease ?
  • Abstract Number: 2037
    Isolated Anti-Ro52 Antibody – Significance and Clinical Association
  • Abstract Number: 14
    Isotype Dependent Performance Of Beta2glycoprotein I Immunoassays In Two Diverse Patient Cohorts: Implications For Assay Harmonization and Standardization
  • Abstract Number: 1362
    Isymind Significantly Reduces MTX-Induced Nausea In a Pilot Trial
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology